In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes. Mayne KJ, Herrington WG. Ann Intern Med 2022 May 3. doi: 10.7326/J22-0029.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mayne KJ, Herrington WG. In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes. Ann Intern Med 2022 May 3. doi: 10.7326/J22-0029.
PMID: 35500259